Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.

about

Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation.Clinical development of rivaroxaban: emerging new clinical evidences?Primary and key secondary results from the ROCKET AF trial, and their implications on clinical practice.

P2860

Q38386998-28438FD5-E2C6-4505-BF8F-76BDEAF22ED4 Q38537785-3F763045-FA7C-4CF9-9AE0-C7DB3E897D78 Q38935753-FD86CE2A-9AE4-4EAD-A700-40B072F8FA84

P2860

Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.

Item

http://www.wikidata.org/entity/Q38221812

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.

@en

type

Item

label

Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.

@en

prefLabel

Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.

@en

P1476

Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.

@en

P2093

Antoni Martínez-Rubio

http://www.w3.org/2001/XMLSchema#string

George Andrei Dan

http://www.w3.org/2001/XMLSchema#string

Juan Carlos Kaski

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Randomized, controlled trials, observational studies, and the hierarchy of research designs

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

Independent predictors of stroke in patients with atrial fibrillation: a systematic review

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Dabigatran versus warfarin in patients with atrial fibrillation

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

P304

933-947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2014.931223

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263292158

http://www.w3.org/2001/XMLSchema#string

P698

24948333

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.

about

P2860

P2860

Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921